These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20687396)

  • 1. Hormone therapy and asymmetrical dimethylarginine in postmenopausal women.
    Karkanaki A; Vavilis D; Traianos A; Kalogiannidis I; Panidis D
    Hormones (Athens); 2010; 9(2):127-35. PubMed ID: 20687396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.
    Teerlink T; Neele SJ; de Jong S; Netelenbos JC; Stehouwer CD
    Clin Sci (Lond); 2003 Jul; 105(1):67-71. PubMed ID: 12625833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women.
    Post MS; Verhoeven MO; van der Mooren MJ; Kenemans P; Stehouwer CD; Teerlink T
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4221-6. PubMed ID: 12970290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study.
    Verhoeven MO; Hemelaar M; van der Mooren MJ; Kenemans P; Teerlink T
    J Intern Med; 2006 Feb; 259(2):199-208. PubMed ID: 16420549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intranasal versus oral hormone therapy on asymmetric dimethylarginine in healthy postmenopausal women: a randomized study.
    Verhoeven MO; Hemelaar M; Teerlink T; Kenemans P; van der Mooren MJ
    Atherosclerosis; 2007 Nov; 195(1):181-8. PubMed ID: 17084844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
    Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
    Böger RH; Bode-Böger SM
    Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asymmetric dimethylarginine as cardiovascular risk factor].
    Galán A; Formiguera X; Rey-Joly C
    Med Clin (Barc); 2008 Sep; 131(7):271-5. PubMed ID: 18775219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials.
    Böger RH
    Vasc Med; 2005 Jul; 10 Suppl 1():S19-25. PubMed ID: 16444865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on asymmetric dimethylarginine of HMR 3339, a novel selective estrogen receptor modulator: a 12-week, randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women.
    Verhoeven MO; Teerlink T; Kenemans P; Vogelvang TE; van der Mooren MJ;
    Menopause; 2007; 14(2):235-42. PubMed ID: 17146377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus.
    Mittermayer F; Pleiner J; Krzyzanowska K; Wiesinger GF; Francesconi M; Wolzt M
    Wien Klin Wochenschr; 2005 Dec; 117(23-24):816-20. PubMed ID: 16437318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine.
    Holden DP; Cartwright JE; Nussey SS; Whitley GS
    Circulation; 2003 Sep; 108(13):1575-80. PubMed ID: 12963642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality.
    Böger RH; Maas R; Schulze F; Schwedhelm E
    Clin Chem Lab Med; 2005; 43(10):1124-9. PubMed ID: 16197309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerobic exercise training decreases plasma asymmetric dimethylarginine concentrations with increase in arterial compliance in postmenopausal women.
    Tanahashi K; Akazawa N; Miyaki A; Choi Y; Ra SG; Matsubara T; Kumagai H; Oikawa S; Maeda S
    Am J Hypertens; 2014 Mar; 27(3):415-21. PubMed ID: 24280041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M; Teerlink T
    Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.
    De Gennaro Colonna V; Bianchi M; Pascale V; Ferrario P; Morelli F; Pascale W; Tomasoni L; Turiel M
    Med Sci Monit; 2009 Apr; 15(4):RA91-101. PubMed ID: 19333216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
    Maas R
    Vasc Med; 2005 Jul; 10 Suppl 1():S49-57. PubMed ID: 16444869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma ADMA concentrations associate with aerobic fitness in postmenopausal women.
    Tanahashi K; Akazawa N; Miyaki A; Choi Y; Ra SG; Matsubara T; Kumagai H; Oikawa S; Miyauchi T; Maeda S
    Life Sci; 2014 Jul; 108(1):30-3. PubMed ID: 24825610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.